TCM
MDT icon

Tuttle Capital Management’s Medtronic MDT Stock Holding History

Tuttle Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-27,616
Closed -$3.13M – 100
2019
Q4 		$3.13M Buy
27,616
+16,496
+148% +$1.81M 1.19% 12
2019
Q3 		$1.2M Buy
+11,120
New +$1.16M 0.32% 87
2018
Q4 		– Sell
-15,390
Closed -$1.51M – 120
2018
Q3 		$1.51M Buy
15,390
+12,790
+492% +$1.18M 0.29% 91
2018
Q2 		$222K Buy
+2,600
New +$217K 0.15% 89

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Tuttle Capital Management's MDT Position: Q1 2020 in Review

Tuttle Capital Management sold out of Medtronic (MDT) in Q1 2020, closing a stake of 27,616 shares — an estimated $3.13M sold.

Tuttle Capital Management first reported a position in MDT in Q2 2018 and held it in 4 quarters. The position peaked at $3.13M in Q4 2019. 1,762 funds tracked by Wall St. Rank hold MDT as of Q1 2020.

  • Tuttle Capital Management reported no remaining Medtronic position as of Q1 2020 after selling out during the quarter.
  • Tuttle Capital Management sold 27,616 Medtronic shares in Q1 2020, an estimated $3.13M.
  • Tuttle Capital Management first reported a position in Medtronic in Q2 2018 and held it in 4 quarters.
  • Tuttle Capital Management's Medtronic position peaked at $3.13M in Q4 2019.
  • 1,762 funds tracked by Wall St. Rank held Medtronic as of Q1 2020.

Based on Tuttle Capital Management's 13F filing for Q1 2020, filed 9 Apr 2020.